SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-19-000259
Filing Date
2019-05-16
Accepted
2019-05-16 06:12:12
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e1349_10q.htm 10-Q 750527
2 EXHIBIT 3.1 e1349_ex3-1.htm EX-3.1 51378
3 EXHIBIT 31.1 e1349_ex31-1.htm EX-31.1 8018
4 EXHIBIT 31.2 e1349_ex31-2.htm EX-31.2 8178
5 EXHIBIT 32.1 e1349_ex32-1.htm EX-32.1 3785
6 EXHIBIT 32.2 e1349_ex32-2.htm EX-32.2 3880
  Complete submission text file 0001731122-19-000259.txt   3669723

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE enob-20190331.xml EX-101.INS 539942
8 XBRL SCHEMA FILE enob-20190331.xsd EX-101.SCH 36666
9 XBRL CALCULATION FILE enob-20190331_cal.xml EX-101.CAL 50092
10 XBRL DEFINITION FILE enob-20190331_def.xml EX-101.DEF 179491
11 XBRL LABEL FILE enob-20190331_lab.xml EX-101.LAB 292411
12 XBRL PRESENTATION FILE enob-20190331_pre.xml EX-101.PRE 261842
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 19830505
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1